Discover the World’s Fastest Business Insights
Get real-time alerts on funding rounds, executive hires, acquisitions, and more— plus verified contact details and AI-powered outreach to connect faster.
Sign up now to unlock exclusive data and opportunities.
Lumen Bioscience Raises $16M Series B Financing to Accelerate Clinical Development of Accessible Biologic Drugs
Lumen Bioscience Raises $16M Series B Financing to Accelerate Clinical Development of Accessible Biologic Drugs
Company Info
Company news
Thu, 05 Jan 2023 08:00:00 GMT
Lumen Bioscience Details 2022 Company and Facilities Growth, New Funding, and Clinical Pipeline Progress - PR Newswire
Fri, 22 Sep 2023 07:00:00 GMT
Lumen Bioscience wins historic $1.5M Wilkes Center Climate Prize - @theU
Tue, 01 Sep 2020 07:00:00 GMT
Lumen Bioscience Raises $16M Series B Financing to Accelerate Clinical Development of Accessible Biologic Drugs - Business Wire
Fri, 22 Sep 2023 07:00:00 GMT
Lumen Bioscience wins historic $1.5 million Wilkes Center Climate Prize at the University of Utah - EurekAlert
Tue, 17 Oct 2023 07:00:00 GMT
Lumen Bioscience awarded $16.2 million in DoD funding to advance LMN-201 through late-stage trials - PR Newswire
Wed, 19 Jul 2023 07:00:00 GMT
Addressing the grand challenge of global access to vaccines - Drug Target Review
Fri, 19 Jan 2024 08:00:00 GMT
Lumen Bioscience pursues oral biologic to prevent recurrent C. diff - Drug Discovery & Development
Tue, 17 May 2022 07:00:00 GMT
Lumen Bioscience Hacks Spirulina to Generate Biologics - Genetic Engineering & Biotechnology News
Thu, 15 Jul 2021 07:00:00 GMT
Seattle startup Lumen Bioscience to build algae manufacturing plant in former bakery - GeekWire
Thu, 24 Mar 2022 07:00:00 GMT
Lumen publishes details of spirulina biomanufacturing platform - European Pharmaceutical Review
Never Miss an Opportunity: Your #1 Sales Intelligence Tool
Get lightning-fast updates on funding rounds, executive hires, contract awards, and more—powered by AI-driven insights to help you connect with the right prospects first.